One of the emerging players in T-ALL biology is CK2 (also known as casein kinase 2), a constitutively active serine/threonine protein kinase whose activity accounts for nearly 20% of the human phosphoproteome and is implicated in a myriad of cellular processes [7,8]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.